| Wang, Yu |
RC48-C012, NCT04400695: A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 |
|
|
| Recruiting | 3 | 366 | RoW | RC48-ADC, RC48, Paclitaxel Injection, Taxol, Docetaxel Injection, Taxotere, Vinorelbine Tartrate Injection, Navelbine, Capecitabine Tablets, Xeloda | RemeGen Co., Ltd. | Breast Cancer | 06/24 | 12/24 | | |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
| Recruiting | 3 | 134 | RoW | albumin paclitaxel, cispatin, tislelizumab | Lai-ping Zhong, Sun Yat-sen University, Fudan University, Central South University, Fujian Medical University | Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Carcinoma | 12/26 | 12/28 | | |
NCT02686151: The Letrozole Administration During Luteal Phase |
|
|
| Not yet recruiting | 3 | 50 | RoW | Letrozole, Femara, Polygeline, polyegline, Sodium Chloride, Natrum muriaticum, dexamethasone, dexametona | The Affiliated Hospital of Inner Mongolia Medical University | Ovarian Hyperstimulation Syndrome | 03/24 | 12/24 | | |
NCT05921305: Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD |
|
|
| Recruiting | 3 | 218 | RoW | MTX, Corticosteroid | Peking University People's Hospital | Acute Graft Versus Host Disease | 06/24 | 12/24 | | |
NCT06558981: Adjuvant Radiotherapy in High Risk Locally Advanced DTC |
|
|
| Recruiting | 3 | 124 | RoW | Radiotherapy, radioiodine treatment | Fudan University | Thyroid Cancer | 06/31 | 06/31 | | |
| Recruiting | 3 | 196 | RoW | Cyclophosphamid, ATG | Peking University People's Hospital | Hematologic Malignancy | 12/24 | 06/25 | | |
NCT04612894: Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer |
|
|
| Not yet recruiting | 2 | 31 | RoW | Camrelizumab and Apatinib, surgery, core needle biopsy | Fudan University | Thyroid Cancer | 12/22 | 12/23 | | |
| Recruiting | 2 | 30 | RoW | Methotrexate, Corticosteroid | Peking University People's Hospital | Acute Graft Versus Host Disease | 12/22 | 01/23 | | |
NCT04787328: A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) |
|
|
| Recruiting | 2 | 30 | RoW | HA121-28 tablets | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Medullary Thyroid Carcinoma | 03/23 | 03/25 | | |
NCT06569524: Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) |
|
|
| Recruiting | 2 | 120 | RoW | TQA2225/AP025 or TQA2225/AP025 Placebo 25mg, TQA2225/AP025 or TQA2225/AP025 Placebo 50mg | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Non-alcoholic Steatohepatitis | 12/26 | 12/27 | | |
NCT04583020: Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma |
|
|
| Recruiting | 2 | 42 | RoW | Camrelizumab, radiation, Temozolomide, TMZ | Peking Union Medical College Hospital, Jiangsu HengRui Medicine Co., Ltd. | Glioblastoma | 12/23 | 12/23 | | |
NCT05123586: A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus |
|
|
| Terminated | 2 | 85 | Europe, US, RoW | LY3361237, Placebo | Eli Lilly and Company | Systemic Lupus Erythematosus | 12/23 | 12/23 | | |
NCT06322394: BXOS110 Injection in the Treatment of Acute Ischaemic Stroke |
|
|
| Recruiting | 2 | 300 | RoW | high-dose BXOS110, BXOS110, low-dose BXOS110, Placebo | Biocells (Beijing) Biotech Co.,Ltd | Acute Ischemic Stroke | 03/25 | 09/25 | | |
NCT06109818: Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis |
|
|
| Recruiting | 2 | 129 | RoW | ICP-488 Tablets, ICP-488 Placebo | Beijing InnoCare Pharma Tech Co., Ltd. | Moderate to Severe Plaque Psoriasis | 10/24 | 11/24 | | |
NCT06494995: AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy |
|
|
| Not yet recruiting | 2 | 52 | RoW | Cadonilimab, Low-dose radiotherapy, SBRT, Capecitabine | Fudan University | Head and Neck Squamous Cell Carcinoma | 07/26 | 07/28 | | |
NCT06077331: A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis |
|
|
| Recruiting | 2 | 120 | RoW | HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched placebo tablets | Hansoh BioMedical R&D Company | Psoriasis | 07/24 | 08/24 | | |
INSIGHT, NCT04995120: Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 42 | RoW | chemotherapy TP regimen combined with Toripalimab, Paclitaxel or Nab-Paclitaxel, Cisplatin | Fudan University | Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Neoplasms | 12/24 | 12/25 | | |
NCT05420597: Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma |
|
|
| Recruiting | 2 | 61 | RoW | Toripalimab, JS001 | Fudan University | Laryngeal Cancer, Hypopharyngeal Cancer | 12/24 | 12/25 | | |
NCT05422066: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma |
|
|
| Recruiting | 2 | 50 | RoW | Selinexor, ATG-010, Xpovio, Rituximab, RiTUXimab Injection, Cyclophosphamide, Cyclophosphamide Injection, Doxorubicin, Doxorubicin Hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product | Li Zhiming, Antengene Corporation | DLBCL Germinal Center B-Cell Type | 07/25 | 12/25 | | |
|
NCT05989425: Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer |
|
|
| Recruiting | 2 | 32 | RoW | surufatinib | Fudan University | Differentiated Thyroid Cancer | 08/26 | 08/26 | | |
NCT05842746: Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma |
|
|
| Not yet recruiting | 2 | 74 | RoW | Elemene, Placebo | Peking Union Medical College Hospital | Glioblastoma, IDH-wildtype | 12/26 | 05/27 | | |
NCT06039631: Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer |
|
|
| Recruiting | 2 | 82 | RoW | Surgery, Radiation, Toripalimab | Fudan University, Fudan University Eye Ear Nose and Throat Hospital, Shanghai Zhongshan Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Ruijin Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Larynx Cancer, Hypopharyngeal Cancer | 09/27 | 09/29 | | |
NCT05102292: The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation |
|
|
| Active, not recruiting | 1/2 | 25 | RoW | HLX208, BRAF V600E inhibitor | Shanghai Henlius Biotech | Anaplastic Thyroid Cancer, ATC | 06/24 | 12/24 | | |
| Recruiting | 1 | 117 | RoW | SG2918 | Hangzhou Sumgen Biotech Co., Ltd. | Advanced Malignant Tumors | 12/25 | 12/26 | | |
| Recruiting | 1 | 125 | Europe, Canada, US | Cohort A1 & A2, KTX-1001, Dexamethasone, Cohort C1 & C2, Carfilzomib, Cohort D, Pomalidomide | K36 Therapeutics, Inc. | Multiple Myeloma, Myeloma, Myeloma Multiple | 12/25 | 06/26 | | |
NCT04312087: Lateral Neck Lymph Node Mapping in Thyroid Cancer |
|
|
| Recruiting | N/A | 250 | RoW | Lateral neck sentinel lymph node biopsy, Modified lateral neck lymph node dissection, Super selective lateral neck lymph node dissection | Fudan University | Thyroid Cancer | 08/21 | 12/22 | | |
| Recruiting | N/A | 75 | RoW | HVPG measurement, Blood test | Nanfang Hospital of Southern Medical University, Beijing YouAn Hospital, Shandong Provincial Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Friendship Hospital, Xingtai People's Hospital, Beijing 302 Hospital | Hypertension, Portal | 01/22 | 06/22 | | |
ASORPWICE, NCT03521739: Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events |
|
|
| Recruiting | N/A | 100000 | RoW | | Chinese Academy of Medical Sciences, Fuwai Hospital | Blood Pressure, Pulse Wave Analysis, Ankle Brachial Index, Patient Outcome Assessment | 12/22 | 12/23 | | |
| Recruiting | N/A | 100 | RoW | Automated peritoneal dialysis, Intermittent hemodialysis | Limeng Chen, First Hospital of China Medical University, First Affiliated Hospital Xi'an Jiaotong University, Beijing Anzhen Hospital, Xiangya Hospital of Central South University, Baxter Healthcare Corporation | Acute Kidney Injury | 12/22 | 12/22 | | |
| Recruiting | N/A | 206 | RoW | automated peritoneal dialysis, IHD | Peking Union Medical College Hospital, First Hospital of China Medical University, Beijing Anzhen Hospital, The Luhe Teaching Hospital of the Capital Medical University, Ningbo No.2 Hospital | ESRD | 12/22 | 02/23 | | |
| Recruiting | N/A | 10254 | RoW | | Limeng Chen | Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder | 12/24 | 12/24 | | |
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults |
|
|
| Recruiting | N/A | 2400 | RoW | Carotid ultrasound examination 1, Carotid ultrasound examination 2 | First Hospital of China Medical University | Carotid Artery Diseases | 08/23 | 07/24 | | |
NCT06062914: Health Economic Research on Oral Nutritional Supplements for Hospitalized Patients With Nutritional Risk |
|
|
| Not yet recruiting | N/A | 30000 | RoW | oral nutritional supplements | Peking Union Medical College Hospital | Malnutrition, Nutritional Risk | 11/23 | 11/23 | | |
NCT02432248: Effect of DHEA on Patients With Poor Ovarian Responds |
|
|
| Recruiting | N/A | 350 | RoW | Dehydroepiandrosterone, DHEA, placebo(medical starch) | The Affiliated Hospital of Inner Mongolia Medical University, First Affiliated Hospital, Sun Yat-Sen University, Renmin Hospital of Wuhan University | Subfertility | 12/23 | 12/24 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
NCT06524167: RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer |
|
|
| Recruiting | N/A | 80 | RoW | adjuvant radiotherapy | Fudan University | Thyroid Cancer | 06/31 | 06/31 | | |
NCT06530316: RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer |
|
|
| Recruiting | N/A | 48 | RoW | RET Inhibitor, Surgery | Fudan University | Thyroid Cancer | 12/26 | 12/29 | | |
NCT06623266: Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC |
|
|
| Recruiting | N/A | 300 | RoW | Neck management | Huashan Hospital | Oral Cancer, Lymph Node Metastasis | 09/26 | 09/28 | | |
COMPLETE Study, NCT06581081: Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for R/r B-cell Acute Lymphoblastic Leukemia |
|
|
| Recruiting | N/A | 130 | RoW | Senl_B19 autologous CAR-T (S1904) treatment | Peking University People's Hospital, The First Affiliated Hospital of Soochow University, Nanfang Hospital, Southern Medical University | Relapsed Adult ALL, B-cell Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL | 08/27 | 08/29 | | |
NCT05926323: Anesthesia Quality Control Indicators of 6 Provinces in Central China |
|
|
| Withdrawn | N/A | 60000000 | NA | | Shanglong Yao | Anesthesia-related Quality Control Indicators, Anesthesia-related Adverse Events | 12/24 | 12/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Chen, Xiujuan |
NCT02686151: The Letrozole Administration During Luteal Phase |
|
|
| Not yet recruiting | 3 | 50 | RoW | Letrozole, Femara, Polygeline, polyegline, Sodium Chloride, Natrum muriaticum, dexamethasone, dexametona | The Affiliated Hospital of Inner Mongolia Medical University | Ovarian Hyperstimulation Syndrome | 03/24 | 12/24 | | |
| Qiao, Peng fei |
NCT06220500: Radiomics Analysis Based on MRI to Detect Brucella Spondylitis |
|
|
| Recruiting | N/A | 100 | RoW | | The Affiliated Hospital of Inner Mongolia Medical University | Brucella Spondylitis | 08/24 | 12/24 | | |
NCT06226324: fMRI Study of Early Brain Injury in Systemic Lupus Erythematosus |
|
|
| Recruiting | N/A | 120 | RoW | neuropsychological test | The Affiliated Hospital of Inner Mongolia Medical University | Systemic Lupus Erythematosus | 06/24 | 12/24 | | |
NCT02809625: Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis |
|
|
| Recruiting | N/A | 100 | RoW | | The Affiliated Hospital of Inner Mongolia Medical University, National Natural Science Foundation of China | Brucella Spondylitis | 12/23 | 12/24 | | |
